ETF Aktie - BSX

Professionelle Tools für Privatanleger.

Premium

Current Price

8,084

Gebot

8,082

Fragen

8,088

Volumen

9.935

8,023 Tagesbereich 8,084

0,00 52-Wochen-Bereich 0,00

Handelsende

8,039

Handelsbeginn

8,024

Letzte Trade

700

8.084

Letzter Handelszeitpunkt

14:36:05

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2009 Financial Results

NATICK, Mass., Jan. 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) will webcast its conference call discussing financial...

Boston Scientific Announces Pricing of $2 Billion of Senior Notes

NATICK, Mass., Dec. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced the pricing of a public offering of $2...

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets...

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets...

Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents

Three models of stenting system now available for palliative treatment of malignant common bile duct strictures NATICK, Mass., Oct. 6...

Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference

NATICK, Mass., Sept. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in the Morgan Stanley...

Boston Scientific to Participate in Thomas Weisel Partners Health Care Conference

NATICK, Mass., Sept. 4 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in the Thomas Weisel...

PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors

NATICK, Mass. and BARCELONA, Sept. 1 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced long-term data from the...

Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failur

Results of landmark heart failure trial published by New England Journal of Medicine and presented at ESC NATICK, Mass., and BARCELONA, Spain...

Boston Scientific Announces Schedule for European Society of Cardiology Congress

NATICK, Mass., Aug. 27 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced the schedule of the Company's major...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
0S90Syros Pharmaceuticals Inc	0,208 € (156,79%)	43,6k
L09Lithium Energi Exploration Inc	0,018 € (56,52%)	1,5k
36GGBM Resources Limited	0,0075 € (36,36%)	38,78k
1B8Ondas Holdings Inc	0,84 € (27,27%)	14,87k
CTNKCentrotherm International AG	4,20 € (27,27%)	55,48k
POTAPortofino Resources Inc	0,0024 € (-53,85%)	1,3k
7KOCullinan Metals Corp	0,0062 € (-36,73%)	10k
L7C2Windfall Geotek Inc	0,0065 € (-31,58%)	2,64k
CNWCodon AG	0,0185 € (-30,19%)	7,9k
97E0Vizsla Copper Corp	0,0322 € (-26,48%)	952
POQ88 Energy Limited	0,0009 € (-10,00%)	2,13M
FMKEcograf Limited	0,0978 € (19,85%)	2,02M
E3BEutelsat Communications	7,895 € (-1,19%)	1,79M
D7GNel ASA	0,1731 € (-0,52%)	1,77M
E3TMetavista 3D Inc	1,82 € (11,66%)	1,3M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

ETF (BSX)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

BSX Neueste Nachrichten

Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2009 Financial Results

Boston Scientific Announces Pricing of $2 Billion of Senior Notes

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents

Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference

Boston Scientific to Participate in Thomas Weisel Partners Health Care Conference

PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors

Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failur

Boston Scientific Announces Schedule for European Society of Cardiology Congress

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

ETF (BSX) Börsenkurse

ETF (BSX)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

BSX Neueste Nachrichten

Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2009 Financial Results

Boston Scientific Announces Pricing of $2 Billion of Senior Notes

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents

Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference

Boston Scientific to Participate in Thomas Weisel Partners Health Care Conference

PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors

Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failur

Boston Scientific Announces Schedule for European Society of Cardiology Congress

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP